Malate dehydrogenase (MDH) EC 1.1.1.37 is a type of oxidoreductase enzyme that is widely found in living organisms in nature. It primarily participates in metabolic pathways such as the tricarboxylic acid cycle (TCA), the glyoxylate cycle, and the malate-aspartate shuttle. This enzyme catalyzes the reversible conversion between oxaloacetate and malate and is one of the key enzymes in the central metabolic pathways of cells. MDH is widely used in the early diagnosis of myocardial infarction, acute parenchymal liver injury, liver cancer, and lung cancer. It is a commonly used enzyme in clinical diagnostics and also has broad market demand in the fields of biopharmaceuticals and chemical testing.
Related Products
The Structure of MDH
MDH exhibits a complex but finely tuned structure, crucial for its enzymatic activity and functional diversity across various organisms. Structurally, MDH belongs to the NAD-dependent dehydrogenase family, with over 100 identified members. Typically, MDH exists as a dimer, each subunit consisting of around 350 residues. Amino acid sequence analysis reveals divergence into distinct phylogenetic groups, suggesting evolutionary relationships with other dehydrogenases like lactate dehydrogenases (LDHs).
The tertiary and quaternary structures of MDH have been extensively studied, revealing homologous active sites and coenzyme binding sites across different species. Crystallographic studies highlight the conserved NAD-binding domain and substrate-binding site within each subunit. The dimer interface consists mainly of interacting α-helices, ensuring stability and enzymatic activity. Mutagenesis studies further elucidate the significance of specific residues in maintaining the dimeric structure and catalytic activity.
Furthermore, MDH's coenzyme specificity is determined by residue 53, crucial for coenzyme binding and hydrogen bonding specificity. Modifications at this residue have been shown to alter coenzyme specificity, demonstrating the intricate relationship between structure and function.
Fig. 1 Three-dimensional structure of monomer of MDH from Escherichia coli (Hall M. D., et al. 1992).
The Function of MDH
Malate dehydrogenase (MDH) plays a crucial role in cellular metabolism by catalyzing the reversible conversion between malate and oxaloacetate. This reaction is a key step in the tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, which is central to cellular respiration. Specifically, MDH facilitates the oxidation of malate to oxaloacetate, generating NADH from NAD+ in the process.
The function of MDH is essential for maintaining the balance of reducing equivalents in the cell, as it participates in the transfer of electrons during cellular respiration. NADH, produced during the oxidation of malate to oxaloacetate, serves as a carrier of high-energy electrons that are ultimately used to generate ATP through oxidative phosphorylation. Conversely, the reduction of oxaloacetate to malate by MDH replenishes NAD+ for subsequent rounds of the TCA cycle, ensuring its continuous operation.
Moreover, MDH is involved in other metabolic pathways beyond the TCA cycle. For instance, it participates in the glyoxylate cycle, which is important for lipid metabolism in plants and bacteria. Additionally, MDH plays a role in the malate-aspartate shuttle, which transports reducing equivalents across mitochondrial membranes to facilitate ATP production in the cytoplasm.
Production of Microbial Malate Dehydrogenase
Microorganisms are ideal sources for MDH production due to their wide availability and short growth cycles. Currently, researchers are employing various methods to obtain high-yield MDH strains, including strain mutagenesis and optimization of fermentation conditions. Additionally, genetic recombination techniques are being used to produce high-yield MDH strains and study the enzyme's physicochemical properties in depth.
Successful overexpression of MDH has been achieved in microorganisms such as Aspergillus oryzae and Saccharomyces cerevisiae, leading to increased yields of D-malate. Cloning and expression of the Tt-MDHs gene from the thermophilic strain HB27 in Escherichia coli have resulted in the production of high-purity and thermostable MDH protein. Similarly, molecular cloning of a 939 bp MDH gene from the Escherichia coli genome has created recombinant strains with significantly high enzyme activity. Furthermore, cloning the cDNA sequence of the MDH gene from Fusarium venenatum revealed a new malate dehydrogenase gene with exceptionally high recombinant protein enzyme activity.
Applications in Disease Diagnostics
The role of MDH extends beyond metabolism into the realm of disease diagnostics. Due to its presence in various tissues and its association with cellular metabolism, MDH levels can serve as biomarkers for certain pathological conditions.
In the context of myocardial infarction (heart attack), elevated levels of MDH are observed in the blood due to the release of the enzyme from damaged cardiac tissue. Therefore, MDH measurement can aid in the early diagnosis of myocardial infarction, enabling prompt medical intervention and improving patient outcomes.
Similarly, acute parenchymal liver injury, such as that caused by hepatotoxic substances or viral infections, leads to increased MDH release into the bloodstream. Monitoring MDH levels can assist in the diagnosis and monitoring of liver damage, guiding treatment decisions and assessing prognosis.
Furthermore, MDH has been implicated in the pathogenesis of certain cancers, including liver cancer and lung cancer. Tumor cells exhibit altered metabolic pathways, including increased glycolysis and altered TCA cycle activity, leading to changes in MDH expression and activity. As such, MDH levels in serum or tissue samples may serve as diagnostic or prognostic markers for these malignancies, aiding in early detection and treatment planning.
Clinical and Industrial Applications
In addition to its role in disease diagnostics, MDH is widely used as a clinical diagnostic enzyme due to its stability and specificity. Assays based on MDH activity are employed in various laboratory tests to assess liver function, cardiac health, and metabolic disorders.
Moreover, MDH has applications in biopharmaceutical production and chemical testing. In the pharmaceutical industry, MDH is utilized in the synthesis of certain drugs and as a quality control enzyme to monitor the purity and efficacy of pharmaceutical products. In chemical testing, MDH assays are employed to detect the presence of specific substrates or inhibitors, aiding in research and development efforts.
Conclusion
Malate dehydrogenase (MDH) is a versatile and essential enzyme with wide-ranging applications in clinical diagnostics, biopharmaceuticals, and chemical testing. Its critical role in central metabolic pathways, combined with its ability to catalyze the reversible conversion between oxaloacetate and malate, underscores its importance in both health and disease. Advances in microbial production of MDH, including strain optimization and genetic recombination, have enabled the large-scale production of this enzyme, meeting the growing demand in various fields. As research continues to uncover new insights into MDH's structure, function, and regulation, its applications are likely to expand, further highlighting its significance in science and medicine.
References
- Hall M.D., et al. Crystal structure of Escherichia coli malate dehydrogenase: A complex of the apoenzyme and citrate at 1.87 Å resolution. Journal of Molecular Biology. 1992, 226 (3): 867-82.
- Takahashi-Íñiguez, T., et al. Function, kinetic properties, crystallization, and regulation of microbial malate dehydrogenase. Journal of Zhejiang University-SCIENCE B. 2016, 17(4): 247-261.
.
